novo nordisk semaglutide shortage Ozempic's patent problem: how lost control of a blockbuster drug. 💉 Demand for GLP-1 weight-loss drugs has exploded, turning Ozempic into a $40bn+ revenue engine for Novo Nordisk. But, despite Novo takes big step toward

From a metabolic health perspective, treating insulin resistance before it progresses to diabetes makes sense

Twenty microliters of each sample, including 2% w/w of sodium lauryl sulfate solution as a positive control, DI water as a negative control, the hydrogel placebo, and the hydrogel containing extract, was placed on the skin using a Finn chamber (Smart Practice, Phoenix, Arizona) and kept in position for 24 hours

With a commitment to both quality care and affordability, Southern Care Anesthetics is dedicated to making BPC-157 therapy accessible for your health and wellness journey

Shima Hadidchi, MD, today to start your personalized treatment plan with Semaglutide GLP-1

Comparing Retatrutide Dosing to Other Medications Understanding how Retatrutide dosing differs from similar medications helps set appropriate expectations

and Canadian federal health authorities as of mid-2025, the primary indication they are used for, and key differentiators between them: In Part 2 , we evaluate how to choose between GLP-1 molecules, using a goal-based approach